Global Antipsychotic Drugs Market, By Therapeutic Class (First Generation, Second Generation, and Third Generation), By Disease (Schizophrenia, Bipolar Disorder, Unipolar Depression, Dementia, and Other Diseases), By Distribution Channel (Hospital Pharmacies, Drug Stores, and Online Pharmacies), By Region and Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends, and Forecast 2023-2032
- Published date: Nov 2023
- Report ID: 99478
- Number of Pages: 346
- Format:
-
keyboard_arrow_up
-
-
- Drive DeVilbissSidhil Ltd.
- ALPS Mountaineering
- Sumitomo Dainippon Pharma Co. Ltd.
- AbbVie Inc. Company Profile
- Alkermes Plc
- AstraZeneca Plc Company Profile
- Reddy's Laboratories Ltd
- Eli Lilly and Company
- Johnson and Johnson
- Otsuka Holdings Co. Ltd
- Teva Pharmaceutical Industries Ltd. Company Profile
- Bristol-Myers Squibb Company
- Other Key Players
- settingsSettings
Our Clients
- 99478
- Nov 2023
Trusted by more than 17382 organizations globally
✖
Request a Sample Report
We'll get back to you as quickly as possible
|
Single User
$6,000
$3,999
USD / per unit
save 24%
|
Multi User
$8,000
$5,999
USD / per unit
save 28%
|
Corporate User
$10,000
$6,999
USD / per unit
save 32%
|
|
|---|---|---|---|
| e-Access | |||
| Report Library Access | |||
| Data Set (Excel) | |||
| Company Profile Library Access | |||
| Interactive Dashboard | |||
| Free Custumization | No | up to 10 hrs work | up to 30 hrs work |
| Accessibility | 1 User | 2-5 User | Unlimited |
| Analyst Support | up to 20 hrs | up to 40 hrs | up to 50 hrs |
| Benefit | Up to 20% off on next purchase | Up to 25% off on next purchase | Up to 30% off on next purchase |
| Buy Now ($ 3,999) | Buy Now ($ 5,999) | Buy Now ($ 6,999) |
